Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Hematology"
DOI: 10.1007/s00277-022-04839-2
Abstract: Polycythemia vera (PV) is a hematopoietic stem cell disorder characterized by janus kinase 2 (JAK2) mutations and an increased cardiovascular risk. Low-risk PV patients (those younger than 60 years of age and without thrombosis history)… read more here.
Keywords: treated glatiramer; successfully treated; risk; polycythemia vera ... See more keywords